Archives

  • Volume 2, Issue 2, Summer 2024

    • The Role Of Upfront Surgery in the Management of Ileal Crohn’s Disease
    • Acute Severe Ulcerative Colitis: Review of Management and Emerging Treatments
    • Treatment Related Adverse Events and Monitoring of Patients Receiving Biologic or Small Molecule Therapy for Inflammatory Bowel Disease
    • Medical Management of Inflammatory Bowel Disease in the Elderly
    • Ophthalmic Complications in Inflammatory Bowel Disease

  • Special Supplement, Fall 2024

    • Upadacitinib for Crohn’s Disease: An alternative to anti-TNF Therapy?

  • Volume 2, Issue 1, Spring 2024

    • The Rising Burden Of Inflammatory Bowel Disease In Canada: Findings From The Crohn’s And Colitis Canada 2023 Impact Of Inflammatory Bowel Disease In Canada Report
    • Perioperative Nutritional Considerations In Patients With Inflammatory Bowel Disease
    • Latest Intestinal Ultrasound Advancements In Inflammatory Bowel Disease
    • Bone Health In Patients With Inflammatory Bowel Disease (IBD): An Overview Of The Epidemiology, Pathogenesis, And Management
    • Updates In The Management Of Pediatric Inflammatory Bowel Disease

  • Special Supplement, November 2023

    • Selective JAK1 Inhibition Using Upadacitinib for the Management of Inflammatory Bowel Diseases: The Powerful Pill

  • Volume 1, Issue 3, October 2023

    • Bringing STRIDE2 to Life in Clinical Practice
    • Practical Approach to Abnormal Liver Enzymes in Patients with Inflammatory Bowel Disease
    • Colorectal Neoplasia Surveillance in Inflammatory Bowel Disease: Updates and Practical Approaches
    • Management of Clostridioides Difficile in IBD Patients
    • Today and Tomorrow: The Use of Biomarkers in Inflammatory Bowel Disease

  • Volume 1, Issue 2, June 2023

    • Surgical Approaches to Perianal Crohn's Disease
    • Advanced Combination Therapy in IBD: Can It Be Achieved With Success?
    • Cutaneous Manifestations of Inflammatory Bowel Disease: Clinical Pearls for Gastroenterologists
    • Post-Operative Crohn's Disease: Current and Emerging Management Techniques
    • Vaccine-Preventable Disease in IBD: Relevance, Guidelines, and Considerations for Implementation
  • issue cover

    Special Supplement, May 2023

    • Targeting IL23p19 Using Risankizumab for the Management of Moderate-to-Severely Active Crohn's disease: The Next Frontier?

  • Volume 1, Issue 1, April 2023

    • JAK Inhibitors for the Treatment of Inflammatory Bowel Disease
    • Management of Pouchitis: Clinical Pearls for the Gastroenterologist
    • Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease: Where Has the Pendulum Swung?
    • Approach to Management of Inflammatory Bowel Disease-Related Arthritis
    • Malnutrition Assessment in Patients with Inflammatory Bowel Disease